CD19 controls Toll-like receptor 9 responses in human B cells

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• CD19 is a B cell-specific costimulatory molecule vital for B-cell receptor (BCR) responses.
• Mutations in the CD19 gene are linked to common variable immunodeficiency (CVID) in humans.
• B-cell responses mediated by BCR and Toll-like receptor 9 (TLR9) are often impaired in CVID patients.

Purpose of the Study:

• To investigate the necessity of CD19 for TLR9 function in human B cells.
• To elucidate the role of CD19 in integrating BCR and TLR9 signaling pathways.

Main Methods:

• Flow cytometry was used to assess B cell activation markers (CD86, TACI, CD23) after anti-IgM or CpG stimulation.
• Phospho flow cytometry, immunoblotting, and co-immunoprecipitation analyzed signaling molecule phosphorylation and interactions.
• Experiments utilized B cells from patients with CD19 gene defects and a B-cell line with CD19 knockdown.

Main Results:

• B cells with defective CD19 alleles exhibited impaired upregulation of activation markers following TLR9 stimulation.
• TLR9 stimulation normally induces CD19 phosphorylation via MYD88/PYK2/LYN complexes, facilitating PI3K recruitment and BTK/AKT phosphorylation.
• Inhibition or deficiency of PI3K, AKT, or BTK mimicked TLR9 activation defects seen in CD19-deficient cells.

Conclusions:

• CD19 is essential for TLR9-induced B-cell activation.
• The CD19/PI3K/AKT/BTK axis is a critical pathway for integrating BCR and TLR9 signaling in human B cells.